Educational information, not medical advice — ask your doctor or midwife.
Indian Sarsaparilla (Hemidesmus indicus) is a slender, woody climber found across the Indian subcontinent. Its fragrant roots — which carry a distinctive vanilla-like scent from the compound 2-hydroxy-4-methoxybenzaldehyde — have been central to Ayurvedic medicine for over 2,000 years. Known in Sanskrit as Sariva or Anantamool ('the endless root'), it holds one of Ayurveda's highest reputations as a Raktashodhak — a purifier of blood and tissues.
The root's key compounds work in a few ways: HMB and related phenolic aldehydes have been shown to dial down inflammatory enzymes and calm immune overreaction. Saponins and lupeol support liver and kidney detoxification pathways, helping the body clear waste products more efficiently. Together, these actions are thought to explain why the herb helps conditions like chronic skin problems, where internal inflammation and sluggish elimination often play a role.
In traditional practice, the root is most often prepared as a decoction (boiled in water) or a cool refreshing drink called Nannari sharbat. Modern products include capsules, tablets, and standardized extracts, which are more convenient but may not fully replicate the synergy of the whole root preparation. Root powder is a good middle ground — it retains most active compounds and can be mixed into warm water, milk, or smoothies.
Sariva is mentioned prominently in the Charaka Samhita and Sushruta Samhita — two of Ayurveda's foundational texts, composed over 2,000 years ago. It was classified as a Medhya Rasayana (rejuvenative for the mind) and a prime Raktashodhak (blood purifier), and was prescribed for conditions ranging from fever and skin disease to urinary complaints and syphilis. In South India, the Nannari sharbat cooling drink made from its roots remains a beloved traditional remedy sold in markets across Tamil Nadu and Karnataka.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
The published evidence for Indian Sarsaparilla (Sariva) is weak or absent. That usually means no controlled trial has tested it, not that a trial found it ineffective — the two are different, and we grade only what has been published.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.